Compare, Analyse Sterling Biotech with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs MYLAN (US) - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   MYLAN
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
MYLAN
Dec-18
STERLING BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs113,561-   
Low Rs31,960-   
Sales per share (Unadj.) Rs26.81,638.8-  
Earnings per share (Unadj.) Rs-15.044.5-  
Cash flow per share (Unadj.) Rs-5.5351.3-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.91,772.8-  
Shares outstanding (eoy) m267.87514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.7 15.4%   
Avg P/E ratio x-0.562.0 -0.7%  
P/CF ratio (eoy) x-1.37.9 -16.2%  
Price / Book Value ratio x0.11.6 8.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8621,420,461 0.1%   
No. of employees `0001.435.0 3.9%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.324,089.9 22.0%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.0654.1 -452.4%   
INCOME DATA
Net Sales Rs m7,181843,147 0.9%  
Other income Rs m430-   
Total revenues Rs m7,223843,147 0.9%   
Gross profit Rs m947218,175 0.4%  
Depreciation Rs m2,543157,870 1.6%   
Interest Rs m4,37740,552 10.8%   
Profit before tax Rs m-5,93119,752 -30.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924-3,142 61.2%   
Profit after tax Rs m-4,00722,895 -17.5%  
Gross profit margin %13.225.9 51.0%  
Effective tax rate %32.4-15.9 -203.9%   
Net profit margin %-55.82.7 -2,054.8%  
BALANCE SHEET DATA
Current assets Rs m14,335470,812 3.0%   
Current liabilities Rs m49,809343,274 14.5%   
Net working cap to sales %-494.015.1 -3,266.0%  
Current ratio x0.31.4 21.0%  
Inventory Days Days40384 482.7%  
Debtors Days Days17193 182.9%  
Net fixed assets Rs m55,432163,557 33.9%   
Share capital Rs m268449 59.7%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,701912,131 1.6%   
Long term debt Rs m9,478984,482 1.0%   
Total assets Rs m73,9882,446,689 3.0%  
Interest coverage x-0.41.5 -23.9%   
Debt to equity ratio x0.61.1 59.7%  
Sales to assets ratio x0.10.3 28.2%   
Return on assets %0.52.6 19.3%  
Return on equity %-27.32.5 -1,085.7%  
Return on capital %-6.43.2 -202.1%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719175,206 1.0%  
From Investments Rs m-3,148-90,562 3.5%  
From Financial Activity Rs m1,426-81,621 -1.7%  
Net Cashflow Rs m-31,452 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare STERLING BIOTECH With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: DR. REDDYS LAB  LUPIN  VENUS REMEDIES  CADILA HEALTHCARE  GLENMARK PHARMA  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - ASTRAZENECA PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS